The global hydrocephalus shunts market was valued at $291.00 million in 2019 and is projected to reach $322.01 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Growth in the number of ...

Fanatical's Play on the Go Elite Bundle lets you grab two Steam Deck-verified games for $15.

Led by the Web3 division of Valve Corporation and co-developed by the original Dota 2 creative team along with top-tier Web3 developers, the AAA-grade metaverse game Dota X has announced the ...

The heart sound recordings can be saved on the device - which can then be used to detect signs of heart valve disease, according to a study published in the IEEE Journal of Biomedical and Health ...

Our Dear Leader has recently ordered the detention of numerous foreigners and immigrants who were in the USA legally – mostly with green cards or student or work visas or ...

Nearly six years since the launch of the smash hit Valve Index, it appears the Steam team is gearing up to start making the ...

Peijia Medical Technology (Suzhou) has teamed up with dsm-firmenich Biomedical business to advance the research and development (R&D) of polymer heart valve materials. The parties have signed a ...

White House trade adviser Peter Navarro has suggested the new tariffs would raise $600 billion annually, which would be the largest tax increase since World War II. Treasury Secretary Scott ...

Amazon's stock dipped due to trade uncertainty, but AWS and digital advertising are driving substantial operating profit growth, making the stock undervalued. AWS, contributing significantly to ...

system to treat tricuspid regurgitation (TR), or a leaky heart valve, offers substantial and sustained improvements in the severity of TR after two years. The results also demonstrate the TriClip ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years ...

Perspective from Gilbert H.L. Tang, MD, MSc, MBA CHICAGO — The first trial to evaluate use of an SGLT2 inhibitor in people undergoing transcatheter aortic valve replacement showed benefit with ...